Annexon, Inc. (ANNX) vs Climb Bio, Inc. (CLYM)
A side-by-side comparison of Annexon, Inc. and Climb Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANNX
Annexon, Inc.
$4.20HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CLYM
Climb Bio, Inc.
$11.05HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ANNX vs CLYM
growth of $100 · dividends reinvested · last 2yANNX -27.0% (-14.5%/yr)CLYM +41.1% (+18.8%/yr)CLYM compounded faster over this window
ANNX CLYM
ANNX vs CLYM: by the numbers
- •ANNX is the larger company ($688M vs $633M market cap).
Metrics side by side
Valuation
| Metric | ANNX | CLYM |
|---|---|---|
| P/B ratio | 3.70 | 2.64 |
Profitability
| Metric | ANNX | CLYM |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -108.93% | -24.06% |
| ROIC | -101.43% | -26.94% |
Growth (annualized)
| Metric | ANNX | CLYM |
|---|---|---|
| Total return CAGR (5Y) | -26.29% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.